Tatjana Stankovic

31 - 40 out of 77Page size: 10

Publications

  1. 2014
  2. Published

    The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia

    Tatjana Stankovic, Jun 2014, In : Leukemia and Lymphoma. 55, 6, p. 1227-39 13 p.

    Research output: Contribution to journal › Article

  3. Published

    ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial

    Tatjana Stankovic, Apr 2014, In : Haematologica. 99, 4, p. 736-42 7 p.

    Research output: Contribution to journal › Article

  4. 2013
  5. Published

    Synthetic Lethality In CLL With DNA Damage Response Defect By Targeting ATR Pathway

    Tatjana Stankovic, Nick Davies, Marwan Cheng Kuang Kwok, Angelo Agathanggelou, 15 Nov 2013, Blood. Vol. 122. p. 120 (Blood).

    Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

  6. Published

    Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia

    Tatjana Stankovic, Aug 2013, In : Leukemia and Lymphoma. 54, 8, p. 1849-53 5 p.

    Research output: Contribution to journal › Article

  7. Published

    BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia

    Angelo Agathanggelou, Victoria Weston, Eva Petermann, Anastasia Zlatanou, Ceri Oldreive, Wenbin Wei, Grant Stewart, Emma Smith, Pamela Kearns & Tatjana Stankovic, Jul 2013, In : Blood Cancer Journal. 3, 7, e126.

    Research output: Contribution to journal › Article

  8. Published

    PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains

    Tatjana Stankovic, 1 Jun 2013, In : Cancer Research. 73, 11, p. 3336-46 11 p.

    Research output: Contribution to journal › Article

  9. 2012
  10. Published

    Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage

    Victoria Weston, Tatjana Stankovic, 1 Apr 2012, In : Leukemia. 26, 4, p. 826-830 5 p.

    Research output: Contribution to journal › Article

  11. Published

    A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia

    Tatjana Stankovic, 1 Mar 2012, In : Leukemia Research. 36, 3, p. 307-310 4 p.

    Research output: Contribution to journal › Article

  12. Published

    KIBRA gene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia

    Tatjana Stankovic, Eamonn Maher & Farida Latif, 1 Mar 2012, In : Epigenetics : official journal of the DNA Methylation Society. 7, 3, p. 211-215 5 p.

    Research output: Contribution to journal › Article

  13. Published

    Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial

    Anna Skowronska, Ceri Oldreive, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 2012, In : Journal of Clinical Oncology . 30, 36, p. 4524-4532 9 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 Next